Filter News
Area of Research
News Topics
- (-) Materials Science (2)
- (-) Molten Salt (1)
- (-) Neutron Science (1)
- 3-D Printing/Advanced Manufacturing (3)
- Artificial Intelligence (2)
- Big Data (1)
- Bioenergy (4)
- Biology (7)
- Biomedical (4)
- Biotechnology (3)
- Buildings (1)
- Chemical Sciences (3)
- Climate Change (5)
- Composites (1)
- Computer Science (5)
- Coronavirus (6)
- Decarbonization (1)
- Energy Storage (1)
- Environment (7)
- High-Performance Computing (5)
- Isotopes (2)
- Machine Learning (2)
- Materials (5)
- Microscopy (1)
- Nanotechnology (3)
- Net Zero (1)
- Partnerships (2)
- Physics (1)
- Simulation (4)
- Summit (3)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
![2023 Battelle Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2023-11/23-G07641-Battelle-Distinguished-Inventor-graphic-pcg_0.jpg?h=d1cb525d&itok=uhmqAKgT)
Four scientists affiliated with ORNL were named Battelle Distinguished Inventors during the lab’s annual Innovation Awards on Dec. 1 in recognition of being granted 14 or more United States patents.
![Distinguished Inventors](/sites/default/files/styles/list_page_thumbnail/public/2020-12/inventors.jpg?h=4631f1c1&itok=xhAGY0kv)
Six scientists at the Department of Energy’s Oak Ridge National Laboratory were named Battelle Distinguished Inventors, in recognition of obtaining 14 or more patents during their careers at the lab.
![ORNL Sign](/sites/default/files/styles/list_page_thumbnail/public/2020-11/ORNLsign.jpg?h=22d0129c&itok=YoZbTjCS)
Seven ORNL scientists have been named among the 2020 Highly Cited Researchers list, according to Clarivate, a data analytics firm that specializes in scientific and academic research.
![An organic solvent and water separate and form nanoclusters on the hydrophobic and hydrophilic sections of plant material, driving the efficient deconstruction of biomass. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2020-11/dark_image_small.png?h=2e111cc1&itok=drKqW05b)
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.